Lasers for lower urinary tract symptoms secondary to benign prostatic hyperplasia: When is the fuss worth it?

被引：1
作者：
Hochreiter W.W. [1 ]
Müller R.M. [1 ]
机构：
[1] Hirslanden Clinic Aarau, Urology Center, Aarau, Schaenisweg
来源：
Current Urology Reports | 2005年 / 6卷 / 4期
关键词：
American Urologic Association; Benign Prostatic Hyperplasia; Holmium Laser; Lower Urinary Tract Symptom; Transurethral Resection;
D O I：
10.1007/s11934-005-0018-1
中图分类号：
学科分类号：
摘要：
In the recent past, several endoscopic procedures using laser technology have evolved for the treatment of benign prostatic hyperplasia. The term “laser treatment of the prostate” comprises a variety of different application systems, different laser wavelengths, and different surgical techniques to eliminate bladder outlet obstruction. The aim of laser prostatectomy is to be less invasive than transurethral electroresection, but equally effective. Promising short-term results led to a booming laser decade in the 1990s, stimulating the development of several devices. However, the emergence of medium-term data has shown that some of these techniques did not stand the test of time due to the lack of long-term efficacy, unacceptable morbidity, and high retreatment rates. Nevertheless, the results of transurethral resection of the prostate are challenged by some of the newer laser devices, putting the socalled “gold standard” into question. © 2005, Current Science Inc.
引用
收藏
页码：257 / 262
页数：5
相关论文
共 59 条
  • [1] Roehrborn C.G., Issa M.M., Bruskewitz R.C., Et al., Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study, Urology, 51, pp. 415-421, (1998)
  • [2] Wheelahan J., Scott N.A., Cartmill R., Et al., Minimally invasive laser techniques for prostatectomy: a systematic review. The ASERNIP-S review group. Australian Safety and Efficacy Register of New Interventional Procedures: Surgical, BJU Int, 86, pp. 805-815, (2000)
  • [3] Dixon C.M., Lasers for the treatment of benign prostatic hyperplasia, Urol Clin North Am, 22, pp. 413-422, (1995)
  • [4] te Slaa E., de la Rosette J.J., Lasers in the treatment of benign prostatic obstruction: past, present, and future, Eur Urol, 30, pp. 1-10, (1996)
  • [5] Wasson J.H., Reda D.J., Bruskewitz R.C., Et al., A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate, N Engl J Med, 332, pp. 75-79, (1995)
  • [6] Horninger W., Unterlechner H., Strasser H., Et al., Transurethral prostatectomy: mortality and morbidity, Prostate, 28, pp. 195-200, (1996)
  • [7] Oesterling J.E., Benign prostatic hyperplasia: medical and minimally invasive treatment options, N Engl J Med, 332, pp. 99-109, (1995)
  • [8] Ansari M.Z., Costello A.J., Jolley D.J., Et al., Adverse events after prostatectomy in Victorian public hospitals, Aust N Z J Surg, 68, pp. 830-836, (1998)
  • [9] Beisland H.O., Sander S., First clinical experiences on neodymium YAG laser irradiation of localized prostatic cancer, Scand J Urol Nephrol, 20, pp. 113-117, (1986)
  • [10] Johnson D.E., Price R.E., Cromeens D.M., Pathologic changes occurring in the prostate following transurethral laser prostatectomy, Lasers Surg Med, 12, pp. 254-263, (1992)
123456